A case of Epstein-Barr virus-negative human immunodeficiency virus-related primary effusion lymphoma

Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved..

Primary effusion lymphoma (PEL) is a rare subtype of large B-cell lymphoma associated with human herpesvirus-8. Most cases are co-infected with Epstein-Barr virus (EBV). The prognosis of PEL is extremely poor and no optimal treatment regimen has been established. We report a case of EBV-negative PEL in a 49-year-old human immunodeficiency virus-positive man, presenting with massive bilateral pleural effusion.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 24(2018), 6 vom: 23. Juni, Seite 487-491

Sprache:

Englisch

Beteiligte Personen:

Ota, Shinichiro [VerfasserIn]
Fujikura, Yuji [VerfasserIn]
Yamamoto, Takayuki [VerfasserIn]
Maki, Yohei [VerfasserIn]
Kurokawa, Atsushi [VerfasserIn]
Maeda, Takuya [VerfasserIn]
Kanoh, Soichiro [VerfasserIn]
Kawana, Akihiko [VerfasserIn]

Links:

Volltext

Themen:

Anti-Retroviral Agents
Antibodies, Viral
Case Reports
DNA, Viral
Epstein–Barr virus (EBV)
Human herpesvirus 8 (HHV-8)
Human immunodeficiency virus (HIV)
Journal Article
Positron emission tomography (PET)
Primary effusion lymphoma (PEL)

Anmerkungen:

Date Completed 01.10.2018

Date Revised 01.10.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jiac.2018.01.011

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM281131643